• Publications
  • Influence
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan
This article presents the revision process, major innovations, and clinimetric testing program for the Movement Disorder Society (MDS)–sponsored revision of the Unified Parkinson's Disease RatingExpand
  • 792
  • 93
  • PDF
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
  • C. Götz, W. Poewe, +9 authors L. Seidl
  • Psychology, Medicine
  • Movement disorders : official journal of the…
  • 1 September 2004
The Movement Disorder Society Task Force for Rating Scales for Parkinson's disease (PD) prepared a critique of the Hoehn and Yahr scale (HY). Strengths of the HY scale include its wide utilizationExpand
  • 1,129
  • 68
  • PDF
Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
  • B. Dubois, D. Burn, +18 authors M. Emre
  • Psychology, Medicine
  • Movement disorders : official journal of the…
  • 15 December 2007
A preceding article described the clinical features of Parkinson's disease dementia (PD‐D) and proposed clinical diagnostic criteria for “probable” and “possible” PD‐D. The main focus of this articleExpand
  • 765
  • 44
Depression rating scales in Parkinson's disease: Critique and recommendations
Depression is a common comorbid condition in Parkinson's disease (PD) and a major contributor to poor quality of life and disability. However, depression can be difficult to assess in patients withExpand
  • 523
  • 42
  • PDF
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
The Movement Disorder Society (MDS) Task Force on Evidence‐Based Medicine (EBM) Review of Treatments for Parkinson's Disease (PD) was first published in 2002 and was updated in 2005 to cover clinicalExpand
  • 866
  • 41
  • PDF
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
The objective was to update previous evidence‐based medicine reviews of treatments for motor symptoms of Parkinson's disease published between 2002 and 2005. Level I (randomized, controlled trial)Expand
  • 373
  • 39
  • PDF
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS)
We aimed to develop and validate a novel rating scale for multiple system atrophy (Unified Multiple System Atrophy Rating Scale ‐ UMSARS). The scale comprises the following components: Part I,Expand
  • 339
  • 28
  • PDF
Treatment of restless legs syndrome: An evidence‐based review and implications for clinical practice
Only in the last three decades, the restless legs syndrome (RLS) has been examined in randomized controlled trials. The Movement Disorder Society (MDS) commissioned a task force to perform anExpand
  • 255
  • 19
  • PDF
Apathy and anhedonia rating scales in Parkinson's disease: Critique and recommendations
Apathy is a common condition in Parkinson's disease (PD) and is generally defined as a lack of motivation. It is associated with more severe cognitive dysfunction and a decrease in activities ofExpand
  • 257
  • 19
  • PDF
Scales to assess psychosis in Parkinson's disease: Critique and recommendations
Psychotic symptoms are a frequent occurrence in Parkinson's disease (PD), affecting up to 50% of patients. The Movement Disorder Society established a Task Force on Rating Scales in PD, and thisExpand
  • 142
  • 13
  • PDF